These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6711101)

  • 1. [Evaluation of the reactogenic and immunogenic properties of the influenza subunit polyvalent vaccine Grippovac SE-AZh during the immunization of schoolchildren].
    Slepushkin AN; Obrosova-Serova NP; Feklisova LV; Bebisheva NI; Mel'nikova SK
    Vestn Akad Med Nauk SSSR; 1984; (1):75-9. PubMed ID: 6711101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 3. Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults).
    Rudenko LG; Zykov MP; Romanov YuA ; Zakharov NG; Leonov VM; Melnikova SK; Chumakov MP
    Acta Virol; 1985 May; 29(3):237-41. PubMed ID: 2864825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine.
    Carle F; Bolgiani M; Zanon P; Moiraghi Ruggenini A; Zotti C
    Boll Ist Sieroter Milan; 1988; 67(2):105-15. PubMed ID: 3067735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunization of elderly subjects with subunit and total virus vaccine containing H1N1 influenza virus].
    Masurel N
    Ned Tijdschr Geneeskd; 1979 Feb; 123(6):196-9. PubMed ID: 418912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the reactivity, safety and immunogenicity of the polyvalent subunit "Grippovak SE-Azh" influenza vaccine in boarding houses for the elderly and disabled].
    Beregovskiĭ NA; Malyshkina LP; Serdiukova LP; Belousova NI; Velikiĭ VN
    Vestn Akad Med Nauk SSSR; 1985; (1):9-12. PubMed ID: 3156457
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza 1980-1.
    Br Med J; 1980 Aug; 281(6239):527-8. PubMed ID: 7427354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influenza vaccination? An extra vaccine for seniors?].
    MMW Fortschr Med; 2003 Sep; 145(37):61. PubMed ID: 14584449
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic results of a committee trial of the new vaccine Grippovac SE-AZh].
    Bashliaeva ZA; Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Ozeretskovskaia NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):49-54. PubMed ID: 3515812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination of a group of young people with influenza virus A/New Jersey/ 1976 (Hsw 1 N 1)].
    Masurel N; de Jong P; Verhoeff WF
    Ned Tijdschr Geneeskd; 1977 Nov; 121(45):1794-800. PubMed ID: 927558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of immunogenicity and safety of domestic influenza vaccines].
    Yao J; Li Q; Xu Q; Feng CF; Lu YM; Xu BQ; Lu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):735. PubMed ID: 15555412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reactivity, safety and immunogenicity of trivalent subunit highly purified 'Grippovak SE-AZh' influenza vaccine tested on young children in children's homes in Moscow].
    Chumakov MP; Malyshkina LP; Zhivin IuN; Dobrokhotova LP; Kontareva MG
    Vestn Akad Med Nauk SSSR; 1985; (1):3-9. PubMed ID: 3976285
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
    Engelhard D; Nagler A; Hardan I; Morag A; Aker M; Baciu H; Strauss N; Parag G; Naparstek E; Ravid Z
    Bone Marrow Transplant; 1993 Jan; 11(1):1-5. PubMed ID: 8431706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S; Weinberger C; Gessner BD
    Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity and influenza virus].
    Melino C
    Clin Ter; 1988 Sep; 126(5):353-62. PubMed ID: 2973965
    [No Abstract]   [Full Text] [Related]  

  • 17. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults.
    Guthrie T; Hobbs CG; Davenport V; Horton RE; Heyderman RS; Williams NA
    J Infect Dis; 2004 Dec; 190(11):1927-35. PubMed ID: 15529256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influenza vaccination of children with hemophilia].
    Klukowska A; Brydak L; Rokicka-Milewska R; Gosk B; Wielopolska M; Adamowicz-Salach A; Rudnicka H; Regnery H; Cox N
    Acta Haematol Pol; 1995; 26(3):305-10. PubMed ID: 8525777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza and influenza vaccination.
    Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD
    Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. School-based influenza immunization.
    Hull HF; Frauendienst RS; Gundersen ML; Monsen SM; Fishbein DB
    Vaccine; 2008 Aug; 26(34):4312-3. PubMed ID: 18577411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.